Asia Business News | Saturday, May 17, 2008
email news alerts
RSS 2.0  
Medical Therapies Limited is an Australian pharmaceutical development company committed to the commercialisation of its drug candidates for cancer and anti-inflammatory conditions including cholecystitis, and distal proctitis. The Company's patent-protected technologies include a number of metal complexes of anti-inflammatory drugs showing increased safety and reduced toxicity in pre-clinical trials. Medical Therapies has also been active is seeking complementary technologies to its existing anti-cancer and anti-inflammatory portfolio.
Company Headquarters Level 6, 40 King Street 
    SYDNEY NSW 2000, AUSTRALIA 
Company Telephone +61 2 9299 0311 
Company Fax +61 2 9299 2198 
Company Principal Sector Health & Pharm 
Company Principal Industry Biotechnology 
Company Homepage www.medicaltherapies.com.au
 
Stock Exchange Stock Code
ASXMTY
News Reader RSS   MEDICAL THERAPIES LIMITED
 Medical Therapies Limited (ASX:MTY) Announce Positive Interim Results From Cuprindo Phase I Clinical Trials (FEB 15, 2008)
Drag Podcast Icon To iTunes - Podcast Download for MEDICAL THERAPIES LIMITED
 Medical Therapies Limited ASX: MTY - Investor Presentation - Ms Maria Halasz , MD and CEO (JUNE 14, 2007)